P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Jacques Banchereau; Carson Harrod; Amanda Cobb; Geneviève Chêne; Louis Sloan; Karolina Palucka; Yves Levy

doi:10.1186/1742-4690-6-S3-P320

Conference papers

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Jacques Banchereau ¹ Carson Harrod ^{1, *} Amanda Cobb ¹ Geneviève Chêne ² Louis Sloan ³ Karolina Palucka ¹ Yves Levy ⁴

* Corresponding author

1 Développement de nouveaux vaccins pour le traitement de maladies virales chroniques

2 ISPED - Institut de Santé Publique, d'Epidémiologie et de Développement

3 North Texas Infectious Diseases Clinic

4 Agence Nationale de Recherche sur le Sida et les hépatites virales

Résumé : n.a

Document type :

Conference papers

Domain :

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadatas

https://www.hal.inserm.fr/inserm-00663917
Contributor : Ed. Bmc <>
Submitted on : Friday, January 27, 2012 - 5:19:55 PM
Last modification on : Wednesday, June 19, 2019 - 11:48:04 AM
Long-term archiving on: : Saturday, April 28, 2012 - 2:42:10 AM

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Files

Identifiers

Collections

Citation

Export

Metrics

175

313

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Files

Identifiers

Collections

Citation

Export

Share

Metrics

175

313